Sold my last holdings of Frasers Centerpoint Trust. Small capital loss of less than 1K, offset by 12K dividends.
They announced they are buying a 25% stake in Serangoon Nex (85 years remaining lease), funded by debt.
Its not a bad deal, not like MapleTree Commercial Trust's disastrous merger a year ago. But its not a great deal either. Their pro-forma calculations show a negligible 0.5% increase in DPU if the transaction had been performed Oct 2021. Leverageis expected to rise from 33% to 38.8% (Section 6.4).
The negatives:
- Serangoon Nex is already crowded with 99.9% occupancy, so I don't see how they can extract more value from it.
- The company announced they are taking on a 410m revolving loan - they did not give the interest rate; revolving loans are usually variable.
- Increasing Leverage from 33 to 38.5% for a mere 0.5% increase in DPU doesn't make sense.
- Sibor has risen from 0.5% to 4% in the last year. This has to affect Singapore property values, increasing FCT's leverage. eg: A 10% decrease in property values would lead to Leverage increasing from 38.5% to 42%. Now we are moving a bit close to MAS' 50% gearing limit.
- How are they going to make future acquisitions, like Northpoint South Wing? They're gonna have to fund it entirely by issuing new shares.
The positives:
- Serangoon Nex is a good long-term asset. Its a hub with 2 MRT lines and a bus interchange. The mall is always crowded.
- On OCBC report stated (p2) that the new debt is taken at an "interest cost of less than 4.3% locked in for three years." I think they are talking about the pro-forma calculations, which would mean these calculations already take into account high interest rates, and the results may be better if the Fed pivots soon.